Willy Skjold

Title: The Innovations of Willy Skjold

Introduction

Willy Skjold, an inventive mind based in Oslo, Norway, has made significant contributions to the field of radiopharmaceuticals. With a focus on in vivo imaging, he has pioneered methods that enhance the labelling of biological targeting molecules, making strides in medical imaging technology.

Latest Patents

Willy Skjold holds a notable patent for a radiolabelling method. This invention pertains to the preparation of lyophilised compositions involving aminooxy-functionalised biomolecules. The method utilizes the radioisotope F for effective labelling, which results in improved imaging quality. Additionally, his invention encompasses radiolabelling techniques using purified materials and provides formulation options such as lyophilised compositions and cassettes that include these refined compounds. The approach is particularly beneficial for use with automated synthesizer apparatuses, showcasing Skjold's innovative contribution to the field.

Career Highlights

Willy Skjold is currently associated with GE Healthcare Limited, a company renowned for its advancements in healthcare technology and medical imaging solutions. His work not only highlights his prowess as an inventor but also aligns with GE's mission of transforming healthcare through innovative technologies.

Collaborations

Willy has collaborated closely with Bard Indrevoll, adding depth to his work through teamwork and shared expertise. Such collaborations enhance the development and application of innovative solutions within the realm of healthcare, further benefitting the industry.

Conclusion

Willy Skjold's contributions to the field of radiopharmaceuticals underscore the importance of innovation in advancing medical technology. His patent demonstrates a commitment to enhancing in vivo imaging techniques, paving the way for future advancements in the medical field. As he continues to innovate, the healthcare community stands to benefit from his creativity and dedication.